½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1444824

¼¼°èÀÇ ¹«¼± ½ÉÀüµµ ±â±â ½ÃÀå : Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)

Wireless ECG Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹«¼± ½ÉÀüµµ ±â±â(Wireless ECG Devices) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 18¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2029³â±îÁö 22¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£(2024-2029³â) µ¿¾È 4.35%ÀÇ CAGR·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¹«¼± ½ÉÀüµµ ±â±â-½ÃÀå

ÆÒµ¥¹Í ±â°£ µ¿¾È COVID-19´Â ¹«¼± ½ÉÀüµµ ±â±â »ê¾÷¿¡ Å« ¿µÇâÀ» ¹ÌÃƽÀ´Ï´Ù. 2021³â 1¿ù À¯·´ ½ÉÀå Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®¿¡ µû¸£¸é, ÀÔ¿øÇÏÁö ¾ÊÀº COVID-19 ȯÀÚ¸¦ ´ë»óÀ¸·Î ½º¸¶Æ®ÆùÀ¸·Î °¡Á¤¿¡¼­ ECG¸¦ ¸ð´ÏÅ͸µÇÑ °á°ú Áúº´ °ü·Ã ½ÉÀå ÇÕº´Áõ°ú ECG º¯È­ÀÇ Á¸À縦 ÆľÇÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í Ãʱ⿡´Â ¾ö°ÝÇÑ ºÀ¼â ±ÔÁ¤À¸·Î ÀÎÇØ ¿ø°Ý ÀÇ·á ¹× °¡»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ÆÒµ¥¹Í ±â°£ µ¿¾È ½ÉÀå Ä¡·á ½Ã¼³¿¡ ´ëÇÑ È¯ÀÚÀÇ Á¢±ÙÀÌ Á¦ÇѵǾú±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº Àü ¼¼°èÀûÀ¸·Î Å« Àα⸦ ²ø¾ú½À´Ï´Ù. µû¶ó¼­ COVID-19´Â ¹«¼± ½ÉÀüµµ ±â±â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃƽÀ´Ï´Ù. ¶ÇÇÑ ÆÒµ¥¹Í ÀÌÈÄ¿¡µµ ¹«¼± ½ÉÀüµµ ±â±â¿¡ ´ëÇÑ ¼ö¿ä´Â ±×´ë·Î À¯ÁöµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹«¼± ½ÉÀüµµ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ³ëÀÎ Àα¸ Áõ°¡, ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡, ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 1¿ù¿¡ ¹ßÇ¥µÈ ¿µ±¹ ½ÉÀå Àç´Ü(BHF) µ¥ÀÌÅÍ¿¡ µû¸£¸é 2021³â¿¡ Àü ¼¼°èÀûÀ¸·Î °¡Àå ÈçÇÑ ½ÉÀå ÁúȯÀº °ü»óµ¿¸Æ(ÇãÇ÷¼º) ½ÉÀå Áúȯ(Àü ¼¼°è À¯º´·ü 2¾ï ¸í ÃßÁ¤), ¸»ÃÊ µ¿¸Æ(Ç÷°ü) Áúȯ(1¾ï 1õ¸¸ ¸í), ³úÁ¹Áß(1¾ï ¸í), ½É¹æ¼¼µ¿(6õ¸¸ ¸í)À̾ú´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ¶ÇÇÑ ºÏ¹ÌÀÇ ½ÉÀå ¹× ¼øȯ±â Áúȯ À¯º´·üÀº 4,600¸¸ ¸í, À¯·´Àº 9,900¸¸ ¸í, ¾ÆÇÁ¸®Ä«´Â 5,800¸¸ ¸í, ³²¾Æ¸Þ¸®Ä«´Â 3,200¸¸ ¸í, ¾Æ½Ã¾Æ¿Í È£ÁÖ´Â 3¾ï 1,000¸¸ ¸íÀ̶ó°í ¾ð±ÞÇß½À´Ï´Ù. µû¶ó¼­ Àü ¼¼°è Àα¸ÀÇ ½ÉÇ÷°ü ÁúȯÀÚ ¼ö°¡ ¸¹À»¼ö·Ï ´õ Á¤È®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ¹«¼± ½ÉÀüµµ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ´Ã¾î³¯ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

¶ÇÇÑ, 2022³â UN¿¡¼­ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é Àü ¼¼°è 65¼¼ ÀÌ»ó Àα¸ÀÇ ºñÁßÀÌ 2022³â 10%¿¡¼­ 2050³â 16%·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇâÈÄ ¸î ³â µ¿¾È ½ÉÀå Áúȯ¿¡ °É¸± °¡´É¼ºÀÌ ³ôÀº ³ë³âÃþÀÇ Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ÁÖ¿ä ¾÷üµéÀÌ ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ È®´ëÇϱâ À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇÏ°í ÀÖ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 1¿ù Philips´Â ºÐ»êÇü ÀÓ»ó½ÃÇè¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Â 12-¸®µå ½ÉÀüµµ ¼Ö·ç¼ÇÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÀÓ»ó µî±Þ ¼Ö·ç¼ÇÀº PhilipsÀÇ ½ÉÀå ¸ð´ÏÅ͸µ Á¦Ç° ¶óÀÎ Áß °¡Àå Áøº¸µÈ ȯÀÚ Á᫐ ½ÉÀüµµÀÔ´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀÇ µ¥ÀÌÅÍ Æǵ¶°ªÀº ÀÓ»ó ȯ°æ¿¡¼­ »ç¿ëµÇ´Â ½ÉÀüµµ¿Í À¯»çÇÕ´Ï´Ù. µû¶ó¼­ °í·É Àα¸ÀÇ Áõ°¡, ½ÉÇ÷°ü ÁúȯÀÚ ¼ö Áõ°¡, ÁÖ¿ä ½ÃÀå Ç÷¹À̾îÀÇ Á¤±âÀûÀÎ ½ÅÁ¦Ç° Ãâ½Ã°¡ ½ÃÀåÀÇ ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

±×·¯³ª ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ º¹ÀâÇÑ È¯±Þ Á¤Ã¥°ú Á¤¹Ð º¸°íÀÇ ¿À·ù·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ µÐÈ­µÉ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¹«¼± ½ÉÀüµµ ±â±â ½ÃÀå µ¿Çâ

¸ð´ÏÅ͸µ ½Ã½ºÅÛ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î ¿¹»ó

½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÏ°í ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ECG ½Ã½ºÅÛ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÏ»ó »ýÈ°¿¡¼­ ȯÀÚÀÇ ½ÉÀåÀÇ Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ³ô¾ÆÁú ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 9¿ù ¹ßÇàµÈ MDPI Àú³ÎÀÇ Á¶»ç ³í¹®¿¡¼­´Â ¸»Ãʵ¿¸ÆÁúȯ(PAD) ¼¼°èÀÇ À¯º´·üÀº 3-12%·Î ÃßÁ¤µÇ°í ÀÖÀ¸¸ç ¹Ì±¹°ú À¯·´ÀÇ ¾à 2,700¸¸¸íÀÌ ÀÌȯ ÇÏ°í ÀÖ´Ù°í º¸°íµÇ¾ú½À´Ï´Ù. ÀÌ Á¤º¸ÅëÀº ¶ÇÇÑ À¯·´¿¡¼­´Â PADÀÇ À¯º´·üÀÌ 45¼¼¿Í 55¼¼ »çÀÌ¿¡¼­ ¾à 17.8%·Î ÃßÁ¤µÇ°í ÀÖ´Ù°í º¸°íÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÇ ³ôÀÌ´Â Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ECG ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµÊ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ Á¶±â ¹ß°ß°ú °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ½ÉÀüµµ ¸ð´ÏÅ͸µ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°è ½ÉÀå ¿¬¸Í(WHF)Àº ¸Å³â 9¿ù 29ÀÏ ¼¼°è ½ÉÀåÀÇ ³¯À» ÃàÇÏÇÕ´Ï´Ù. WHF´Â 2022³â 9¿ù ½ÉÀå °Ç°­¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀÌ´Â Ä·ÆäÀÎÀ» °èȹÇÏ°í ÀÖ½À´Ï´Ù. ¸Å³â 90°³ ÀÌ»óÀÇ ±¹°¡°¡ ÀÌ ±¹Á¦ Çà»ç¿¡ Âü¿©ÇÕ´Ï´Ù. ±× °á°ú ¼¼°è ½ÉÀåÀÇ ³¯Àº ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ Á¤º¸¸¦ ÀüÆÄÇÏ´Â È¿°úÀûÀÎ ¼ö´ÜÀÓÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù.

Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ECG ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇÏ´Â µ¥ ÇÊ¿äÇÑ Çõ½ÅÀûÀÎ Á¦Ç° Ãâ½Ãµµ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, Biotricity´Â 2022³â 4¿ù ¹Ì±¹ FDAÀÇ ½ÂÀÎÀ» ¹ÞÀº ¹«¼± ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡ Biotres¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Á¦Ç°Àº 2022³â 2¿ù ÇϼøºÎÅÍ ÀÇ»ç, Ŭ¸®´Ð, º´¿ø ¹× °³ÀÎ »ç¿ëÀÚ¸¦ À§ÇÑ ¼±ÁÖ¹®À» ½ÃÀÛÇß½À´Ï´Ù.

ºÏ¹Ì¿¡¼­´Â ¿¹Ãø ±â°£ µ¿¾È ¹«¼± ½ÉÀüµµ ±â±â ½ÃÀåÀÇ ¼ºÀåÀÌ ¿¹»ó

ºÏ¹Ì´Â ¹«¼± ½ÉÀüµµ ±â±â ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È ºñ½ÁÇÑ °æÇâÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ µî ¿äÀÎÀÌ Á¶»ç ´ë»ó Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â ½ÉÀ庴 ¹× ³úÁ¹Áß Åë°è ÃֽŠ»ç½Ç ½ÃÆ®¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¾à 40Ãʸ¶´Ù ÇÑ ¸íÀÌ ½É±Ù °æ»öÀ» ÀÏÀ¸Å³ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¶Âù°¡Áö·Î 2021³â 9¿ù¿¡ ¾÷µ¥ÀÌÆ®µÈ CDC´Â ¹Ì±¹ÀÇ 40¼¼ ÀÌ»ó ¾à 650¸¸ ¸íÀÌ ¸»ÃÊ µ¿¸Æ ÁúȯÀ» ¾Î°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ Ä³³ª´Ù ½ÉÀå³úÁ¹ÁßÀç´ÜÀÇ 2022³â 2¿ù º¸°í¼­¿¡ µû¸£¸é ±¹³»¿¡¼­´Â 75¸¸¸íÀÌ ½ÉºÎÀüÀ» °®°í ÀÖÀ¸¸ç ¸Å³â 10¸¸¸íÀÌ ½ÉºÎÀüÀ¸·Î Áø´ÜµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç¿Í ºó¹øÇÑ Á¦Ç° ½ÂÀÎ, Ãâ½Ã ¹× °³¹ßÀÌ ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 10¿ù¿¡ QT MedicalÀº ¼Ò¾Æ ȯÀÚ¿¡°Ô »ç¿ëµÇ´Â 12À¯µµ ½ÉÀüµµ PCA 500¿¡ ´ëÇÑ FDA Àΰ¡¸¦ ÃëµæÇß½À´Ï´Ù. ÀÌ ½ÂÀÎÀº ½Å»ý¾Æ, À¯¾Æ, ¼Ò¾Æ, û¼Ò³âÀ» Æ÷ÇÔÇÑ ¸ðµç ¼Ò¾Æ Áý´Ü¿¡ ´ëÇÑ »ç¿ë ÀûÀÀÀ» È®´ëÇß½À´Ï´Ù.

µû¶ó¼­ ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ µî À§ÀÇ ¿äÀÎ, ÁÖ¿ä Á¦Ç°ÀÇ Ãâ½Ã°¡ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹«¼± ½ÉÀüµµ ±â±â »ê¾÷ °³¿ä

¹«¼± ½ÉÀüµµ ±â±â ½ÃÀåÀº ½ÃÀå¿¡ ¼Ò¼öÀÇ ´ë±â¾÷°ú ¼Ò±Ô¸ð ±â¾÷ÀÌ Àֱ⠶§¹®¿¡ Àû´çÈ÷ ÅëÇÕµÈ ½ÃÀåÀÔ´Ï´Ù. ½ÃÀå °ü°èÀÚ´Â ½ÃÀåÀ» À§ÇØ ±â¼úÀûÀ¸·Î ÷´Ü Á¦Ç°À» °³¹ßÇϱâ À§ÇÑ ¿¬±¸ °³¹ß¿¡ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷Àº Nihon Kohden Corporation, Medtronic, General Electric Company (GE Healthcare), Aerotel Medical Systems, AliveCor Inc., µîÀÔ´Ï´Ù.

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ùÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»ç ÀüÁ¦ Á¶°Ç ¹× ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå °³¿ä
  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
    • °í·ÉÀÚ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü Áúȯ ¹ß»ý·ü Áõ°¡
    • ¹«¼± ±â¼úÀÇ ºñ¿ë ÀúÇÏ
    • ¿ø°Ý °¨½Ã ±â¼ú Áøº¸
  • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
    • ½ÉÇ÷°ü Áúȯ(CVD)¿¡ °üÇÑ º¹ÀâÇÑ »óȯ Á¤Ã¥
    • Á¤È®ÇÑ º¸°í¼­ÀÇ ºÎÁ¤È®¼º
  • Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ´ëü Á¦Ç°ÀÇ À§Çù
    • °æÀï ±â¾÷ °£ °æÀï°ü°èÀÇ ½É°¢¼º

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

  • Á¦Ç° À¯Çüº°
    • ECG ½Ã½ºÅÛ ¸ð´ÏÅ͸µ
      • ¿ø°Ý µ¥ÀÌÅÍ ¸ð´ÏÅ͸µ
      • À̺¥Æ® ¸ð´ÏÅ͸µ
      • Áö¼ÓÀûÀÎ ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
    • Áø´Ü¿ë ECG ½Ã½ºÅÛ
      • ÈÞ½Ä ½Ã ½ÉÀüµµ ½Ã½ºÅÛ
      • ½ºÆ®·¹½º ½ÉÀüµµ ½Ã½ºÅÛ
      • ȦÅÍ ½ÉÀüµµ ½Ã½ºÅÛ
  • ÃÖÁ¾ »ç¿ëÀÚº°
    • º´¿ø
    • ÀçÅà »ç¿ëÀÚ
    • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ
  • Áö¿ª
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
    • À¯·´
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • GCC
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¹Ì
      • ºê¶óÁú
      • ¾Æ¸£ÇîƼ³ª
      • ±âŸ ³²¹Ì

Á¦6Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Aerotel Medical Systems Ltd
    • AliveCor Inc.
    • BPL Medical Technologies
    • Bittium
    • CardioComm Solutions Inc.
    • GE Healthcare
    • iRhythm Technologies Inc.
    • MediBioSense Ltd
    • Medtronic PLC
    • Nihon Kohden Corporation
    • Dozee
    • QT Medical

Á¦7Àå ½ÃÀå ±âȸ ¹× ÇâÈÄ µ¿Çâ

LYJ 24.03.22

The Wireless ECG Devices Market size is estimated at USD 1.84 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 4.35% during the forecast period (2024-2029).

Wireless ECG Devices - Market

Over the pandemic period, COVID-19 had a significant impact on the wireless ECG device industry. As per the article published by the European Heart Journal in January 2021, home ECG monitoring with the help of smartphones in non-hospitalized COVID-19 patients was able to identify disease-related cardiac complications and the presence of ECG alterations. Moreover, the COVID-19 pandemic increased the demand for telehealth and virtual solutions due to the strict lockdown regulations imposed at the initial stages of the pandemic. Since there was limited patient access to cardiac care facilities during the pandemic, these remote monitoring systems were immensely popular across the world. Hence, COVID-19 had a significant impact on the wireless ECG device market. In addition, the demand for wireless ECG devices is expected to remain intact during the post-pandemic period.

The major factors driving the growth of the wireless ECG devices market include the growing geriatric population, the increasing incidence of cardiovascular diseases, and technological advancements in remote monitoring technologies. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million), and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe it was 99 million, in Africa it was 58 million, in South America it was 32 million, and in Asia and Australia it was 310 million. Thus, the high number of cardiovascular diseases in the world's population is likely to increase the demand for wireless ECG devices because they are more accurate and easier to use. This will help the market grow.

Additionally, the report published by the UN in 2022 mentioned that the share of the global population aged 65 years or older is projected to rise from 10% in 2022 to 16% in 2050. Over the next few years, the growth of the market is also expected to be helped by the growing number of older people who are more likely to get heart diseases.

Furthermore, major players are adopting various strategies to grow their presence in the market, which may further fuel market growth. For instance, in January 2022, Philips launched the 12-lead electrocardiogram solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centered ECG in the company's line of cardiac monitoring products. Its data readings are similar to those of ECGs used in clinical settings. Thus, the growth of the market is likely to be helped by the growing number of older people, the high number of people with cardiovascular diseases, and the regular release of new products by key market players.

But the growth of the market is likely to be slowed by complicated reimbursement policies for cardiovascular diseases and errors in precision reporting.

Wireless ECG Devices Market Trends

The Monitoring Systems Segment is Expected to be the Fastest Growing Segment During the Forecast Period

The continuous cardiovascular monitoring ECG systems segment is expected to grow over the forecast period, due to the increasing incidence of cardiovascular diseases and a growing geriatric population, which is likely to increase the need for continuous cardiovascular monitoring of patients' hearts during their daily routines. For instance, the MDPI Journal research article published in September 2021 reported that the worldwide prevalence of peripheral arterial disease (PAD) is estimated to be 3-12%, affecting nearly 27 million people in America and Europe. The same source also reported that in Europe, the prevalence of PAD is estimated at around 17.8% between the ages of 45 and 55. Such a high prevalence of cardiovascular diseases is expected to contribute to the growing demand for continuous cardiovascular monitoring ECG systems, thereby fueling segment growth.

Increasing awareness regarding the early detection and management of cardiovascular diseases is augmenting the demand for continuous cardiovascular ECG monitoring devices. For instance, the World Heart Federation (WHF) celebrates World Heart Day on September 29 every year. WHF has planned a campaign to raise awareness of heart health in September 2022.Over 90 countries take part in this international observance every year. As a result, World Heart Day has proven to be an effective means for disseminating information about cardiovascular disorders.

The innovative product launches necessary to meet the growing demand for continuous cardiovascular monitoring ECG systems are also expected to boost segment growth. For instance, in April 2022, Biotricity launched its US FDA-cleared, wireless wearable cardiac monitoring device, Biotres. The product was available for pre-order to physicians, medical offices, hospitals, and individual users as of late February 2022.

North America is Expected to Witness a Growth in Wireless ECG Devices Market Over the Forecast Period

North America holds a major share of the wireless ECG devices market, and it is expected to show a similar trend over the forecast period. Factors such as the growing geriatric population and increasing incidence of cardiovascular diseases fuel the market growth in the studied region. For instance, as per the 2022 Heart Disease and Stroke Statistics Update Fact Sheet, approximately every 40 seconds, a person in the United States is anticipated to have a myocardial infarction. Likewise, the CDC updated in September 2021 reported that approximately 6.5 million people aged 40 and older in the United States have peripheral arterial disease. Also, as per the February 2022 report from the Heart and Stroke Foundation of Canada, 750,000 people are living with heart failure, and 100,000 people are diagnosed with heart failure each year in the country.

Furthermore, the presence of key players and frequent product approvals, launches, and developments are expected to contribute to the growth of the market in this region. For instance, in October 2022, QT Medical received FDA clearance for PCA 500, aresting 12-lead electrocardiogram for use in pediatric patients. This clearance expanded its indication for use to all pediatric populations, including newborns, infants, children and adolescents.

Therefore, the above mentioned factors such as growing geriatric population and increasing incidence of cardiovascular diseases, key product launches are expected to contribute to the growth of the market in this region.

Wireless ECG Devices Industry Overview

The wireless ECG devices market is a moderately consolidated market, owing to the presence of a few major players and smaller players in the market. The market players are focusing on R&D to develop technologically advanced products for the market. The major market players are Nihon Kohden Corporation, Medtronic, General Electric Company (GE Healthcare), Aerotel Medical Systems, and AliveCor Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Incidence of Cardiovascular Diseases
    • 4.2.2 Declining Cost of Wireless Technologies
    • 4.2.3 Technological Advancements in Remote Monitoring Technologies
  • 4.3 Market Restraints
    • 4.3.1 Complex Reimbursement Policies Regarding Cardiovascular Diseases (CVD)
    • 4.3.2 Inaccuracies in Precision Reporting
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product Type
    • 5.1.1 Monitoring ECG Systems
      • 5.1.1.1 Remote Data Monitoring
      • 5.1.1.2 Event Monitoring
      • 5.1.1.3 Continuous Cardiovascular Monitoring Systems
    • 5.1.2 Diagnostic ECG Systems
      • 5.1.2.1 Rest ECG Systems
      • 5.1.2.2 Stress ECG Systems
      • 5.1.2.3 Holter ECG Systems
  • 5.2 By End User
    • 5.2.1 Hospital
    • 5.2.2 Home-based User
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aerotel Medical Systems Ltd
    • 6.1.2 AliveCor Inc.
    • 6.1.3 BPL Medical Technologies
    • 6.1.4 Bittium
    • 6.1.5 CardioComm Solutions Inc.
    • 6.1.6 GE Healthcare
    • 6.1.7 iRhythm Technologies Inc.
    • 6.1.8 MediBioSense Ltd
    • 6.1.9 Medtronic PLC
    • 6.1.10 Nihon Kohden Corporation
    • 6.1.11 Dozee
    • 6.1.12 QT Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦